<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32453150</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-8689</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Nursing</Title><ISOAbbreviation>Nursing</ISOAbbreviation></Journal><ArticleTitle>Amyotrophic lateral sclerosis: Nursing care and considerations.</ArticleTitle><Pagination><StartPage>32</StartPage><EndPage>39</EndPage><MedlinePgn>32-39</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/01.NURSE.0000662348.31823.44</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative disease that is always fatal, although treatment can help slow disease progression. This article discusses the etiology and pathophysiology, signs and symptoms, diagnosis, and clinical management of ALS, with special nursing considerations to help patients at the end of life.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vacca</LastName><ForeName>Vincent M</ForeName><Initials>VM</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Vincent M. Vacca, Jr., is an associate lecturer at the University of Massachusetts in Boston, Mass., and a member of the Nursing2020 editorial board.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nursing</MedlineTA><NlmUniqueID>7600137</NlmUniqueID><ISSNLinking>0360-4039</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000451" MajorTopicYN="Y">nursing</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009733" MajorTopicYN="N">Nursing Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013727" MajorTopicYN="N">Terminal Care</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32453150</ArticleId><ArticleId IdType="doi">10.1097/01.NURSE.0000662348.31823.44</ArticleId><ArticleId IdType="pii">00152193-202006000-00011</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Maragakis NJ, Galvez-Jimenez N. Epidemiology and pathogenesis of amyotrophic lateral sclerosis. UptoDate. 2019. www.uptodate.com.</Citation></Reference><Reference><Citation>Christidi F, Karavasilis E, Rentzos M, Kelekis N, Evdokimidis I, Bede P. Clinical and radiological markers of extra-motor deficits in amyotrophic lateral sclerosis. Front Neurol. 2018;9:1005.</Citation></Reference><Reference><Citation>Brown RH Jr. Amyotrophic lateral sclerosis and other motor neuron diseases. In: Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, eds. Harrison's Principles of Internal Medicine. 20th ed. New York, NY: McGraw-Hill; 2018:429.</Citation></Reference><Reference><Citation>Maz&#xf3;n M, V&#xe1;zquez Costa JF, Ten-Esteve A, Mart&#xed;-Bonmat&#xed; L. Imaging biomarkers for the diagnosis and prognosis of neurodegenerative diseases. The example of amyotrophic lateral sclerosis. Front Neurosci. 2018;12:784.</Citation></Reference><Reference><Citation>Yip DW, Lui F. Physiology, Motor Cortical. Treasure Island, FL: StatPearls Publishing; 2019.</Citation></Reference><Reference><Citation>Javed K, Lui F. Neuroanatomy, Lateral Corticospinal Tract. Treasure Island, FL: StatPearls Publishing; 2018.</Citation></Reference><Reference><Citation>Johnson JH, Al Khalili Y. Histology, Myelin. Treasure Island, FL: StatPearls Publishing; 2019.</Citation></Reference><Reference><Citation>Nowicka N, Juranek J, Juranek JK, Wojtkiewicz J. Risk factors and emerging therapies in amyotrophic lateral sclerosis. Int J Mol Sci. 2019;20(11):E2616.</Citation></Reference><Reference><Citation>Stallard CN, Saadabadi A. Biochemisty, Glutamate. Treasure Island, FL: StatPearls Publishing; 2020.</Citation></Reference><Reference><Citation>Emos MC, Rosner J. Neuroanatomy, Upper Motor Nerve Signs. Treasure Island, FL: StatPearls Publishing; 2019.</Citation></Reference><Reference><Citation>Lohia A, McKenzie J. Neuroanatomy, Pyramidal Tract Lesions. Treasure Island, FL: StatPearls Publishing; 2019.</Citation></Reference><Reference><Citation>Larson TC, Kaye W, Mehta P, Horton DK. Amyotrophic lateral sclerosis mortality in the United States, 2011-2014. Neuroepidemiology. 2018;51(1-2):96&#x2013;103.</Citation></Reference><Reference><Citation>Sanchez B, Rutkove SB. Electrical impedance myography and its applications in neuromuscular disorders. Neurotherapeutics. 2017;14:107&#x2013;118.</Citation></Reference><Reference><Citation>Bond L, Ganguly P, Khamankar N, et al. A comprehensive examination of percutaneous endoscopic gastrostomy and its association with amyotrophic lateral sclerosis patient outcomes. Brain Sci. 2019;9(9):E223.</Citation></Reference><Reference><Citation>Schultz J. Disease-modifying treatment of amyotrophic lateral sclerosis. Am J Manag Care. 2018;24(15 suppl):S327&#x2013;S335.</Citation></Reference><Reference><Citation>Long R, Havics B, Zembillas M, Kelly J, Amundson M. Elucidating the end-of-life experience of persons with amyotrophic lateral sclerosis. Holist Nurs Pract. 2019;33(1):3&#x2013;8.</Citation></Reference><Reference><Citation>US National Library of Medicine. Amyotrophic lateral sclerosis. www.clinicaltrials.gov/ct2/home.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>